Santhanam Sundar
5PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 13, 2025
The Real-World Impact of PARP Inhibitor Maintenance Therapy in High Grade Serous Tubo-Ovarian and Peritoneal Cancers.Maryam Al-Ani, Bahaaeldin Baraka, Navin Mathiyalagan
|Aug 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.Simon J Crabb, Syed Hussain, Eileen Soulis
|Jul 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.Nicholas D James, Fiona C Ingleby, Noel W Clarke
|Jul 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease.Michel Bolla, Anouk Neven, Philippe Maingon
|Apr 29, 2021
Adjuvant Hormone Therapy After Prostate Radiation: Is This Data Torture?Santhanam Sundar, Micheal Ocathail
Pageof 1
Frequent Collaborators
2 joint publications
Joe M O'Sullivan
2 joint publications
Alison J Birtle
2 joint publications
Robert J Jones
1 joint publications
Michel Bolla
1 joint publications
Anouk Neven
1 joint publications
Philippe Maingon
1 joint publications
Srinivasan Madhusudan
1 joint publications
Karine Peignaux-Casasnovas
1 joint publications
Amit Bahl
1 joint publications
Christopher D Scrase
